Inventor · disambiguated record
Fabienne Mackay
Also filed as: MACKAY FABIENNE
10 granted patents·8 pending applications·289 citations·filing 1999–2019
91Inventor score
Top patents by PatentIndex Score
18 records- 0197US7083785B2Methods of treatment by administering an anti-BCMA antibodyBIOGEN IDEC INC·Filed 2002·Granted Aug 1, 2006·151 cites·18 claims
- 0293US9650430B2Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)BIOGEN MA INC·Filed 2014·Granted May 16, 2017·8 cites·10 claims
- 0393US6869605B2BAFF, inhibitors thereof and their use in the modulation of B-cell responseBIOGEN IDEC INC·Filed 2001·Granted Mar 22, 2005·75 cites·14 claims
- 0490US9545086B2BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disordersMACKAY FABIENNE·Filed 2008·Granted Jan 17, 2017·16 cites·17 claims
- 0584US10494416B2Methods of modulating immune responses using BCMA polypeptideBIOGEN MA INC·Filed 2017·Granted Dec 3, 2019·1 cites·7 claims
- 0683US7309492B2Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosusBIOGEN IDEC INC·Filed 2001·Granted Dec 18, 2007·13 cites·7 claims
- 0781US7744891B2Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseasesBIOGEN IDEC INC·Filed 2007·Granted Jun 29, 2010·3 cites·35 claims
- 0879US8828669B2Methods of screening for a compound that inhibits the interaction between BAFF and BCMABROWNING JEFFREY·Filed 2012·Granted Sep 9, 2014·1 cites·2 claims
- 0976US2020095305A1Methods of modulating immune responses using bcma polypeptideBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 1072US7255854B1Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseasesBIOGEN INC·Filed 1999·Granted Aug 14, 2007·21 cites·35 claims
- 1164US2010233179A1BAFF, inhibitors thereof and their use in the modulation of B-cell responseBROWNING JEFFREY·Filed 2009·Application pending·0 cites
- 1258US2005100548A1BAFF, inhibitors thereof and their use in the modulation of B-cell responseBIOGEN IDEC INC·Filed 2004·Application pending·0 cites
- 1356US2006079457A1BAFF, inhibitors thereof and their use in the modulation of B-cell responseBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 1455US2005169924A1BAFF, inhibitors thereof and their use in the modulation of B-cell responseBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 1554US8287874B2Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseasesBROWNING JEFFREY L·Filed 2010·Granted Oct 16, 2012·0 cites·29 claims
- 1652US2008254030A1Use of Baff to Treat Th2-Mediated ConditionsMACKAY CHARLES·Filed 2006·Application pending·0 cites
- 1752US2005244411A1BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disordersBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 1847US2003095967A1BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disordersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fabienne Mackay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →